FDA product code SGB: Pain Assessment Software In Non-Communicative Adults

SGB is the FDA product code for pain assessment software in non-communicative adults. It is a Class II device, regulated under 21 CFR 882.1472 and reviewed by the Neurology panel. Devices under SGB reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

Pain assessment software in non-communicative adults is a prescription-only device that combines information from clinical pain domains to produce an output indicative of a patient’s current level of pain in conscious adult patients who are unable to communicate their current pain level. This device is intended for adjunctive use and not intended as a stand-alone diagnostic or prognostic tool.

Classification

FieldValue
Device namePain Assessment Software In Non-Communicative Adults
Device classClass II
Regulation21 CFR 882.1472
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)

Recalls for SGB devices

FDA recall records list no recalls for product code SGB.

Frequently asked questions

What is FDA product code SGB?

SGB is the FDA product code for pain assessment software in non-communicative adults. It is a Class II device, regulated under 21 CFR 882.1472 and reviewed by the Neurology panel.

What device class is SGB?

Class II, regulation 21 CFR 882.1472. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times